Literature DB >> 9227189

Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolaemia induced by a wheat starch-casein diet.

R Menéndez1, L Arruzazabala, R Más, A Del Río, A M Amor, R M González, D Carbajal, V Fraga, V Molina, J Illnait.   

Abstract

The effect of policosanol, a mixture of high-molecular-weight aliphatic alcohols isolated from sugarcane wax, on casein-induced hypercholesterolaemia in rabbits was studied. When policosanol was administered by the oral route once daily for 30 d (50 mg/kg) the increases in plasma total cholesterol and LDL-cholesterol (LDC-C) were significantly reduced when compared with the control group. The incorporation of 3H2O into sterols in the liver was significantly depressed, suggesting inhibition of hepatic cholesterol biosynthesis. The oral administration of policosanol raised the rate of removal of 125I-labelled LDL from serum. Kinetic parameters calculated following injection of [125I]LDL showed than in casein-fed rabbits, the terminal half-life (t1/2) was significantly decreased after policosanol treatment. The hepatic LDL-binding activity was increased after policosanol administration which suggested that the enhanced clearance was due, at least in part, to increased receptor-mediated uptake of LDL by the liver. Considered together, these results suggest that policosanol can significantly reduce the increase of plasma LDL-C in rabbits fed on a wheat starch-casein diet by reducing cholesterol biosynthesis in the liver. Such an effect could account for the enhancement of LDL catabolism through the receptor-mediated pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9227189     DOI: 10.1079/bjn19970090

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  18 in total

1.  Activation of AMP-kinase by policosanol requires peroxisomal metabolism.

Authors:  Subhashis Banerjee; Sarbani Ghoshal; Todd D Porter
Journal:  Lipids       Date:  2011-02-27       Impact factor: 1.880

2.  Policosanol for managing human immunodeficiency virus-related dyslipidemia in a medically underserved population: a randomized, controlled clinical trial.

Authors:  Barbara Swanson; Joyce K Keithley; Beverly E Sha; Louis Fogg; Judith Nerad; Richard M Novak; Oluwatoyin Adeyemi; Gregory T Spear
Journal:  Altern Ther Health Med       Date:  2011 Mar-Apr       Impact factor: 1.305

3.  Effects of long-term supplementation of policosanol on blood cholesterol/glucose levels and 3-hydroxy-3-methylglutaryl coenzyme a reductase activity in a rat model fed high cholesterol diets.

Authors:  Jung-Yun Lee; Hwang-Yong Choi; Yu-Ri Kang; Hung-Bae Chang; Hyoung-Sik Chun; Mee-Sook Lee; Young-In Kwon
Journal:  Food Sci Biotechnol       Date:  2016-06-30       Impact factor: 2.391

4.  Effects of combination treatment with policosanol and omega-3 fatty acids on platelet aggregation: A randomized, double-blind clinical study.

Authors:  Gladys Castaño; Maria L Arruzazabala; Lilia Fernández; Rosa Mas; Daisy Carbajal; Vivian Molina; José Illnait; Sarahí Mendoza; Rafael Gámez; Melbis Mesa; Julio Fernández
Journal:  Curr Ther Res Clin Exp       Date:  2006-05

5.  Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro.

Authors:  R Menéndez; R Más; A M Amor; R M González; J C Fernández; I Rodeiro; M Zayas; S Jiménez
Journal:  Br J Clin Pharmacol       Date:  2000-09       Impact factor: 4.335

6.  Effects of policosanols and phytosterols on lipid levels and cholesterol biosynthesis in hamsters.

Authors:  Y W Wang; P J H Jones; I Pischel; C Fairow
Journal:  Lipids       Date:  2003-02       Impact factor: 1.880

7.  Policosanol as a new inhibitor candidate for vascular calcification in diabetic hyperlipidemic rats.

Authors:  Mohamed M Elseweidy; Nabila Zein; Samih E Aldhamy; Marwa M Elsawy; Saeid A Saeid
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-25

8.  Regulation of HMGCoA reductase activity by policosanol and octacosadienol, a new synthetic analogue of octacosanol.

Authors:  Simonetta Oliaro-Bosso; Emanuela Calcio Gaudino; Stefano Mantegna; Enrico Giraudo; Claudia Meda; Franca Viola; Giancarlo Cravotto
Journal:  Lipids       Date:  2009-09-11       Impact factor: 1.880

9.  Octacosanol administration to humans decreases neutral sterol and bile acid concentration in feces.

Authors:  Sylvia Keller; Franziska Gimmler; Gerhard Jahreis
Journal:  Lipids       Date:  2007-11-15       Impact factor: 1.880

10.  Anti-Aging and Tissue Regeneration Ability of Policosanol Along with Lipid-Lowering Effect in Hyperlipidemic Zebrafish via Enhancement of High-Density Lipoprotein Functionality.

Authors:  Eun-Young Lee; Jeong-Ah Yoo; So-Mang Lim; Kyung-Hyun Cho
Journal:  Rejuvenation Res       Date:  2016-02-12       Impact factor: 4.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.